Premier Path Wealth Partners’s Idexx Laboratories IDXX Stock Holding History

Premier Path Wealth Partners’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$202K	Sell	386 -86	-18%	-$47.1K	0.02%	375
2026 Q2	$248K	Sell	472 -82	-15%	-$46K	0.03%	378
2026 Q1	$311K	Buy	554 +42	+8%	+$26.9K	0.04%	340
2025 Q4	$346K	Buy	512 +72	+16%	+$49K	0.04%	307
2025 Q3	$281K	Buy	440 +43	+11%	+$26.1K	0.04%	341
2025 Q2	$213K	Buy	+397	New	+$190K	0.03%	373
2024 Q4	–	Sell	-530	Closed	-$268K	–	378
2024 Q3	$268K	Sell	530 -116	-18%	-$56.4K	0.04%	321
2024 Q2	$315K	Buy	646 +80	+14%	+$40.2K	0.05%	284
2024 Q1	$307K	Sell	566 -6	-1%	-$3.28K	0.06%	271
2023 Q4	$317K	Buy	+572	New	+$269K	0.07%	246

Other funds holding IDXX

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.6B AUM 22.09% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

AustralianSuper Melbourne, Australia $24.4B AUM 44.82% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Premier Path Wealth Partners's IDXX Position: Q3 2026 in Review

Premier Path Wealth Partners reduced its Idexx Laboratories (IDXX) stake by 18% in Q3 2026, selling an estimated $47.1K and leaving 386 shares worth $202K. The position accounts for 0.02% of the portfolio, ranked #375.

Premier Path Wealth Partners first reported a position in IDXX in Q4 2023 and has held it in 10 quarters since. The position peaked at $346K in Q4 2025. 804 funds tracked by Wall St. Rank hold IDXX as of Q3 2026.

Premier Path Wealth Partners held 386 shares of Idexx Laboratories worth $202K as of Q3 2026.
Premier Path Wealth Partners sold 86 Idexx Laboratories shares in Q3 2026, an estimated $47.1K.
Idexx Laboratories made up 0.02% of Premier Path Wealth Partners's portfolio in Q3 2026, its #375 holding.
Premier Path Wealth Partners first reported a position in Idexx Laboratories in Q4 2023 and has held it in 10 quarters since.
Premier Path Wealth Partners's Idexx Laboratories position peaked at $346K in Q4 2025.
804 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2026.

Based on Premier Path Wealth Partners's 13F filing for Q3 2026, filed 16 Oct 2026.